Bruce J. Kinon

10.6k citations

153 papers · 7.4k indexed · 1 hit paper · h-index 47

Psychiatry and Mental health top 0.1%
Cellular and Molecular Neuroscience top 1%
Clinical Psychology top 1%
Cognitive Neuroscience top 2%
Molecular Biology top 10%

Co-authors: J. A. Gilmore Jeffrey A. Lieberman Haya Ascher‐Svanum Virginia L. Stauffer Bruce R. Basson John M. Kane Gary D. Tollefson Sara Kollack‐Walker
Topics: Schizophrenia research and treatment (121 papers)Bipolar Disorder and Treatment (39 papers)Treatment of Major Depression (22 papers)
Cited by: Psychiatry and Mental health Biological Psychiatry Philosophy
Journals: SHILAP Revista de lepidopterologíaPLoS ONE American Journal of Psychiatry
Partner nations: United States United Kingdom Denmark

In The Last Decade

Bruce J. Kinon

153 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1994 474 citations Bruce J. Kinon et al. profile →

Peers

Countries citing papers authored by Bruce J. Kinon

Since Specialization

Citations

This map shows the geographic impact of Bruce J. Kinon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce J. Kinon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce J. Kinon more than expected).

Fields of papers citing papers by Bruce J. Kinon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce J. Kinon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce J. Kinon. The network helps show where Bruce J. Kinon may publish in the future.

Co-authorship network of co-authors of Bruce J. Kinon

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce J. Kinon. A scholar is included among the top collaborators of Bruce J. Kinon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce J. Kinon. Bruce J. Kinon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine 2022 ·Journal of Psychopharmacology ·Daniela Fonseca de Freitas,Giouliana Kadra-Scalzo,Deborah Agbedjro,Emma Francis,(unknown),Megan Pritchard,Hitesh Shetty,Aviv Segev,Cecilia Casetta,Sophie E. Smart,Johnny Downs,Søren Rahn Christensen,Nikolaj Bak,Bruce J. Kinon,Daniel Ståhl,James H. MacCabe,Richard D. Hayes	5
2	Clinical correlates of early onset antipsychotic treatment resistance 2022 ·Journal of Psychopharmacology ·Daniela Fonseca de Freitas,Deborah Agbedjro,Giouliana Kadra-Scalzo,Emma Francis,(unknown),Megan Pritchard,Hitesh Shetty,Aviv Segev,Cecilia Casetta,Sophie E. Smart,Anna Morris,Johnny Downs,Søren Rahn Christensen,Nikolaj Bak,Bruce J. Kinon,Daniel Ståhl,Richard D. Hayes,James H. MacCabe	4
3	A predictor model of treatment resistance in schizophrenia using data from electronic health records 2022 ·PLoS ONE ·Giouliana Kadra-Scalzo,Daniela Fonseca de Freitas,Deborah Agbedjro,Emma Francis,(unknown),Megan Pritchard,Hitesh Shetty,Aviv Segev,Cecilia Casetta,Sophie E. Smart,Anna Morris,Johnny Downs,Søren Rahn Christensen,Nikolaj Bak,Bruce J. Kinon,Daniel Ståhl,Richard D. Hayes,James H. MacCabe	7
4	A machine-learning framework for robust and reliable prediction of short- and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data 2020 ·Translational Psychiatry ·(unknown),(unknown),(unknown),M. Axelsen,Nikolaj Bak,Lars Arvastson,Søren Rahn Christensen,Louise Baruël Johansen,Jayachandra M. Raghava,Bob Oranje,Egill Rostrup,Mette Ødegaard Nielsen,Merete Osler,Birgitte Fagerlund,Christos Pantelis,Bruce J. Kinon,Birte Glenthøj,Lars Kai Hansen,Bjørn H. Ebdrup	32
5	Exploratory Analysis for a Targeted Patient Population Responsive to the Metabotropic Glutamate 2/3 Receptor Agonist Pomaglumetad Methionil in Schizophrenia 2015 ·Biological Psychiatry ·Bruce J. Kinon,Brian A. Millen,Lu Zhang,David L. McKinzie	125
6	Bone Loss Associated with Hyperprolactinemia in Patients with Schizophrenia 2013 ·Clinical Schizophrenia & Related Psychoses ·Bruce J. Kinon,Hong Liu‐Seifert,Virginia L. Stauffer,Jayanthi Jacob	32
7	Negative symptoms in schizophrenia – the remarkable impact of inclusion definitions in clinical trials and their consequences 2013 ·Schizophrenia Research ·Jonathan Rabinowitz,Nomi Werbeloff,Ivo Caers,Francine S. Mandel,Virginia L. Stauffer,François Ménard,Bruce J. Kinon,Shitij Kapur	65
8	Combining efficacy and completion rates with no data imputation: A composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials 2013 ·European Neuropsychopharmacology ·Jonathan Rabinowitz,Nomi Werbeloff,Ivo Caers,Francine S. Mandel,Judith Jaeger,Virginia L. Stauffer,François Ménard,Bruce J. Kinon,Shitij Kapur	1
9	The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial 2011 ·BMC Psychiatry ·Lei Chen,Glenn Phillips,Joseph A. Johnston,Bruce J. Kinon,Haya Ascher‐Svanum,Sara Kollack‐Walker,Paul Succop,Dieter Naber	9
10	A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia 2011 ·Journal of Clinical Psychopharmacology ·Bruce J. Kinon,Lu Zhang,Brian A. Millen,Olawale Osuntokun,(unknown),Sara Kollack‐Walker,Kimberley Jackson,Ludmila Kryzhanovskaya,(unknown)	190
11	Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms 2011 ·Schizophrenia Research ·Virginia L. Stauffer,(unknown),Bruce J. Kinon,Haya Ascher‐Svanum,Lei Chen,Peter D. Feldman,Robert R. Conley	34
12	Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives 2010 ·Current Medical Research and Opinion ·Haya Ascher‐Svanum,Allen W. Nyhuis,Virginia L. Stauffer,Bruce J. Kinon,Douglas E. Faries,Glenn Phillips,Kory Schuh,A. George Awad,Richard S.E. Keefe,Dieter Naber	44
13	Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis 2010 ·Psychiatry Research ·Virginia L. Stauffer,Michael Case,Bruce J. Kinon,Robert R. Conley,Haya Ascher‐Svanum,Sara Kollack‐Walker,John M. Kane,Joseph P. McEvoy,Jeffrey A. Lieberman	52
14	Predictors and correlates for weight changes in patients co-treated with olanzapine and weight mitigating agents; a post-hoc analysis 2009 ·BMC Psychiatry ·Virginia L. Stauffer,Ilya Lipkovich,Vicki Poole Hoffmann,Alexandra N. Heinloth,(unknown),Bruce J. Kinon	19
15	Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia 2009 ·BMC Psychiatry ·Douglas E. Faries,Haya Ascher‐Svanum,Allen W. Nyhuis,Bruce J. Kinon	37
16	Longitudinal Effect of Olanzapine on Fasting Serum Lipids: A Randomized, Prospective, 4‐Month Study 2004 ·Annals of the New York Academy of Sciences ·Bruce J. Kinon,Hong Liu‐Seifert,Jonna Ahl,Saeeduddin Ahmed,Robert W. Baker	6
17	Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone 2003 ·Psychoneuroendocrinology ·Bruce J. Kinon,J. A. Gilmore,Hong Liu,Uriel Halbreich	285
18	Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials 2003 ·Psychoneuroendocrinology ·Bruce J. Kinon,J. A. Gilmore,Hong Liu,Uriel Halbreich	121
19	A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data 2001 ·International Journal of Geriatric Psychiatry ·John Kennedy,Frank P. Bymaster,Leslie M. Schuh,David O. Calligaro,George G. Nomikos,Christian C. Felder,(unknown),Bruce J. Kinon,Robert W. Baker,Donald P. Hay,Helmut Roth,Martín Dossenbach,Christopher Kaiser,Charles M. Beasley,John H. Holcombe,Mark B. Effron,Alan Breier	29
20	Controlled, Double-Blind Investigation of the Clozapine Discontinuation Symptoms With Conversion to Either Olanzapine or Placebo 1999 ·Journal of Clinical Psychopharmacology ·G.D. Tollefson,Mary Anne Dellva,(unknown),John M. Kane,Donna A. Wirshing,Bruce J. Kinon	43

About Bruce J. Kinon

Bruce J. Kinon is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Philosophy, having authored 153 papers that have together received 7.4k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (121 papers), Bipolar Disorder and Treatment (39 papers) and Treatment of Major Depression (22 papers). The work is most often cited by research in Psychiatry and Mental health (5.0k citations), Biological Psychiatry (517 citations) and Philosophy (789 citations). Bruce J. Kinon has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include J. A. Gilmore, Jeffrey A. Lieberman, Haya Ascher‐Svanum, Virginia L. Stauffer, Bruce R. Basson, John M. Kane, Gary D. Tollefson, Sara Kollack‐Walker, Uriel Halbreich and Hong Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact